Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is epalrestat an effective treatment for diabetic peripheral neuropathy?

Nature Clinical Practice Endocrinology & Metabolism volume 3, pages 84–85 (2007)Cite this article

boxed-textHotta N et al. (2006) Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial. Diabetes Care 29: 1538–1544

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Tesfaye S et al. (2005) Vascular risk factors and diabetic neuropathy. N Engl J Med 352: 341–350

    Article  CAS  Google Scholar 

  2. Malik RA et al. (2005) Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia 48: 578–585

    Article  CAS  Google Scholar 

  3. Tesfaye S et al. (1993) Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography. Diabetologia 36: 1266–1274

    Article  CAS  Google Scholar 

  4. Kennedy WR (2004) Opportunities afforded by the study of unmyelinated nerves in skin and other organs. Muscle Nerve 29: 756–767

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Floor Q, Royal Hallamshire Hospital, Sheffield S10 2JF, UK solomon.tesfaye@sth.nhs.uk

Authors and Affiliations

  1. S Tesfaye is the Head of Diabetes Research, Sheffield Teaching Hospitals, and the Chair of the Diabetic Neuropathy Study Group of the European Association for the Study of Diabetes, Royal Hallamshire Hospital, Sheffield, UK.,

    Solomon Tesfaye

Authors
  1. Solomon Tesfaye
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tesfaye, S. Is epalrestat an effective treatment for diabetic peripheral neuropathy?. Nat Rev Endocrinol 3, 84–85 (2007). https://doi.org/10.1038/ncpendmet0395

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0395

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing